1-17 of 17
David W. Scott
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study

Tomohiro Urata, Yusuke Naoi, Aixiang Jiang, Merrill Boyle, Kazutaka Sunami, Toshi Imai, Yuichiro Nawa, Yasushi Hiramatsu, Kazuhiko Yamamoto, Soichiro Fujii, Isao Yoshida, Tomofumi Yano, Ryota Chijimatsu, Hiroyuki Murakami, Kazuhiro Ikeuchi, Hiroki Kobayashi, Katsuma Tani, Hideki Ujiie, Hirofumi Inoue, Shuta Tomida, Akira Yamamoto, Takumi Kondo, Hideaki Fujiwara, Noboru Asada, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Ken-ichi Matsuoka, Keisuke Sawada, Shuji Momose, Jun-ichi Tamaru, Asami Nishikori, Yasuharu Sato, Tadashi Yoshino, Yoshinobu Maeda, David W. Scott, Daisuke Ennishi
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7459–7470.
https://doi.org/10.1182/bloodadvances.2023010402
Published: 2023
Includes: Supplemental data
Journal Articles

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

John R. Davies, Laura K. Hilton, Aixiang Jiang, Sharon Barrans, Catherine Burton, Peter W. M. Johnson, Andrew J. Davies, Ming-Qing Du, Reuben Tooze, Francesco Cucco, Matthew A. Care, Ryan D. Morin, Christian Steidl, Chulin Sha, David R. Westhead, David W. Scott
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6156–6162.
https://doi.org/10.1182/bloodadvances.2023010673
Published: 2023
Includes: Supplemental data
Journal Articles

Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma

Diego Villa, Aixiang Jiang, Carlo Visco, Nicola Crosbie, Rory McCulloch, Michael J. Buege, Anita Kumar, David A. Bond, Jonas Paludo, Matthew J. Maurer, Gita Thanarajasingam, Katharine L. Lewis, Chan Y. Cheah, Joachim Baech, Tarec C. El-Galaly, Laveniya Kugathasan, David W. Scott, Alina S. Gerrie, David Lewis
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4576–4585.
https://doi.org/10.1182/bloodadvances.2023009804
Published: 2023
Includes: Supplemental data
Journal Articles

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, Brendan Hodkinson, Emil Kumar, Thomas Cummin, Margaret Ashton-Key, Sharon Barrans, Suzan van Hoppe, Cathy Burton, Mohamed Elshiekh, Simon Rule, Nicola Crosbie, Andrew Clear, Maria Calaminici, Hendrik Runge, Robert K. Hills, David W. Scott, Lisa M. Rimsza, Geetha Menon, Chulin Sha, John R. Davies, Ai Nagano, Andrew Davies, Daniel Painter, Alexandra Smith, John Gribben, Kikkeri N. Naresh, David R. Westhead, Jessica Okosun, Andrew Steele, Daniel J. Hodson, Sriram Balasubramanian, Peter Johnson, Jun Wang, Jude Fitzgibbon
Journal: Blood Advances
Blood Adv (2023) 7 (5): 845–855.
https://doi.org/10.1182/bloodadvances.2022007536
Published: 2023
Includes: Supplemental data
Journal Articles

The outcome of older adults with classic Hodgkin lymphoma in British Columbia

Phoebe T. M. Cheng, Diego Villa, Alina S. Gerrie, Ciara L. Freeman, Graham W. Slack, Randy D. Gascoyne, Pedro Farinha, Jeffrey W. Craig, Brian Skinnider, Don Wilson, David W. Scott, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5924–5932.
https://doi.org/10.1182/bloodadvances.2022008258
Published: 2022
Includes: Supplemental data
Journal Articles

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5482–5493.
https://doi.org/10.1182/bloodadvances.2022008355
Published: 2022
Includes: Supplemental data
Journal Articles

Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma

Clinical Trials & Observations
Diego Villa, Eva Hoster, Olivier Hermine, Wolfram Klapper, Michal Szymczyk, André Bosly, Michael Unterhalt, Lisa M. Rimsza, Colleen A. Ramsower, Ciara L. Freeman, David W. Scott, Alina S. Gerrie, Kerry J. Savage, Laurie H. Sehn, Martin Dreyling
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5285–5294.
https://doi.org/10.1182/bloodadvances.2022007371
Published: 2022
Journal Articles

Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach

Clinical Trials & Observations
Phoebe T. M. Cheng, Diego Villa, R. Petter Tonseth, David W. Scott, Alina S. Gerrie, Ciara L. Freeman, Tom Pickles, Andrea C. Lo, Pedro Farinha, Jeffrey W. Craig, Graham W. Slack, Randy D. Gascoyne, François Bénard, Don Wilson, Brian Skinnider, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3647–3655.
https://doi.org/10.1182/bloodadvances.2021004375
Published: 2021
Journal Articles

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Clinical Trials & Observations
Malgorzata Nowicka, Laura K. Hilton, Margaret Ashton-Key, Chantal E. Hargreaves, Chern Lee, Russell Foxall, Matthew J. Carter, Stephen A. Beers, Kathleen N. Potter, Christopher R. Bolen, Christian Klein, Andrea Knapp, Farheen Mir, Matthew Rose-Zerilli, Cathy Burton, Wolfram Klapper, David W. Scott, Laurie H. Sehn, Umberto Vitolo, Maurizio Martelli, Marek Trneny, Christopher K. Rushton, Graham W. Slack, Pedro Farinha, Jonathan C. Strefford, Mikkel Z. Oestergaard, Ryan D. Morin, Mark S. Cragg
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2945–2957.
https://doi.org/10.1182/bloodadvances.2021004770
Published: 2021
Includes: Supplemental data
Journal Articles

Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors

Vignesh Shanmugam, Jeffrey W. Craig, Laura K. Hilton, Matthew H. Nguyen, Christopher K. Rushton, Kian Fahimdanesh, Scott Lovitch, Ben Ferland, David W. Scott, Jon C. Aster
Journal: Blood Advances
Blood Adv (2021) 5 (1): 71–83.
https://doi.org/10.1182/bloodadvances.2020002995
Published: 2021
Includes: Supplemental data
Journal Articles

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma

Clinical Trials & Observations
Diego Villa, Laurie H. Sehn, Kerry J. Savage, Cynthia L. Toze, Kevin Song, Wendie D. den Brok, Ciara L. Freeman, David W. Scott, Alina S. Gerrie
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3486–3494.
https://doi.org/10.1182/bloodadvances.2020002068
Published: 2020
Includes: Supplemental data
Journal Articles

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma

Christopher K. Rushton, Sarah E. Arthur, Miguel Alcaide, Matthew Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, Nicole Thomas, Laura K. Hilton, Neil Michaud, Scott Daigle, Jordan Davidson, Kevin Bushell, Stephen Yu, Ryan N. Rys, Michael Jain, Lois Shepherd, Marco A. Marra, John Kuruvilla, Michael Crump, Koren Mann, Sarit Assouline, Joseph M. Connors, Christian Steidl, Mark S. Cragg, David W. Scott, Nathalie A. Johnson, Ryan D. Morin
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2886–2898.
https://doi.org/10.1182/bloodadvances.2020001696
Published: 2020
Includes: Supplemental data
Journal Articles

Gene expression profiling of gray zone lymphoma

Clémentine Sarkozy, Lauren Chong, Katsuyoshi Takata, Elizabeth A. Chavez, Tomoko Miyata-Takata, Gerben Duns, Adèle Telenius, Merrill Boyle, Graham W. Slack, Camille Laurent, Pedro Farinha, Thierry J. Molina, Christiane Copie-Bergman, Diane Damotte, Gilles A. Salles, Anja Mottok, Kerry J. Savage, David W. Scott, Alexandra Traverse-Glehen, Christian Steidl
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2523–2535.
https://doi.org/10.1182/bloodadvances.2020001923
Published: 2020
Includes: Supplemental data
Journal Articles

Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray

Clinical Trials & Observations
Diego Villa, King L. Tan, Christian Steidl, Susana Ben-Neriah, Muntadhar Al Moosawi, Tamara N. Shenkier, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage, David W. Scott, Randy D. Gascoyne, Graham W. Slack
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3953–3961.
https://doi.org/10.1182/bloodadvances.2019000989
Published: 2019
Includes: Supplemental data
Journal Articles

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Clinical Trials & Observations
Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M. Connors, David W. Scott, Maher K. Gandhi, Kerry J. Savage, Tarec El-Galaly, Diego Villa, Chan Yoon Cheah
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2013–2021.
https://doi.org/10.1182/bloodadvances.2019000251
Published: 2019
Journal Articles

High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology

Lauren C. Chong, Susana Ben-Neriah, Graham W. Slack, Ciara Freeman, Daisuke Ennishi, Anja Mottok, Brett Collinge, Pau Abrisqueta, Pedro Farinha, Merrill Boyle, Barbara Meissner, Robert Kridel, Alina S. Gerrie, Diego Villa, Kerry J. Savage, Laurie H. Sehn, Reiner Siebert, Ryan D. Morin, Randy D. Gascoyne, Marco A. Marra, Joseph M. Connors, Andrew J. Mungall, Christian Steidl, David W. Scott
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2755–2765.
https://doi.org/10.1182/bloodadvances.2018023572
Published: 2018
Includes: Supplemental data
Journal Articles

Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo

Kalpana Parvathaneni, David W. Scott
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2332–2340.
https://doi.org/10.1182/bloodadvances.2018018556
Published: 2018
Includes: Supplemental data